Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial Article

Vogel, Victor G, Costantino, Joseph P, Wickerham, D Lawrence et al. (2006). Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial . OBSTETRICAL & GYNECOLOGICAL SURVEY, 61(10), 650. 10.1097/01.ogx.0000238648.23538.42

cited authors

  • Vogel, Victor G; Costantino, Joseph P; Wickerham, D Lawrence; Cronin, Walter M; Cecchini, Reena S; Atkins, James N; Bevers, Therese B; Fehrenbacher, Louis; Pajon, Eduardo R; Wade, James L; Robidoux, André; Margolese, Richard G; James, Joan; Lippman, Scott M; Runowicz, Carolyn D; Ganz, Patricia A; Reis, Steven E; McCaskill-Stevens, Worta; Ford, Leslie C; Jordan, V Craig; Wolmark, Norman

authors

publication date

  • October 1, 2006

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 42 Health Sciences
  • 4203 Health Services and Systems
  • 6.1 Pharmaceuticals
  • Aging
  • Breast Cancer
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Estrogen
  • Health Disparities
  • Patient Safety
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • Wolters Kluwer

start page

  • 650

volume

  • 61

issue

  • 10